Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer

Masayuki Shiraki, Tetsuyo Odajima, Tatsuru Ikeda, Aya Sasaki, Masaaki Satoh, Akira Yamaguchi, Makoto Noguchi, Itaru Nagai, Hiroyoshi Hiratsuka

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

p53, cyclin D1 and epidermal growth factor receptor (EGFR) are molecular markers that regulate the cell cycle or cell growth and play important roles in tumor development and progression. In this study, we examined the impact of immunohistochemical expression of these markers on tumor progression in 140 oral cancers. p53, cyclin D1 and EGFR were expressed in 64 cases (46%), 54 cases (39%) and 54 cases (39%), respectively, but there was no inter-relationship between any two of these markers. In the association of these markers with clinicopathological features, EGFR expression alone was significantly associated with poor differentiation (P=0.0008) and invasive growth pattern (P=0.0003). Any of these markers, including EGFR, had no significant impact on survival. Coexpression of all these markers, however, was significantly associated with invasive growth pattern (P=0.0149) and shortened survival (P=0.0181), and was a significant and independent unfavorable prognostic factor (P=0.0002), along with tumor size (P=0.0040), nodal metastasis (P=0.0137) and growth pattern (P=0.0017) in a multivariate analysis. Simultaneous coexpression of these markers in oral cancers might prove to be a useful indicator for identification of low- or high-risk patients.

Original languageEnglish
Pages (from-to)1482-1489
Number of pages8
JournalModern Pathology
Volume18
Issue number11
DOIs
Publication statusPublished - 2005 Nov
Externally publishedYes

Fingerprint

Mouth Neoplasms
Cyclin D1
Epidermal Growth Factor Receptor
Growth
Survival
Tumor Biomarkers
Neoplasms
Cell Cycle
Multivariate Analysis
Neoplasm Metastasis

Keywords

  • Coexpression
  • Cyclin D1
  • EGFR
  • Oral cancer
  • p53
  • Prognosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. / Shiraki, Masayuki; Odajima, Tetsuyo; Ikeda, Tatsuru; Sasaki, Aya; Satoh, Masaaki; Yamaguchi, Akira; Noguchi, Makoto; Nagai, Itaru; Hiratsuka, Hiroyoshi.

In: Modern Pathology, Vol. 18, No. 11, 11.2005, p. 1482-1489.

Research output: Contribution to journalArticle

Shiraki, M, Odajima, T, Ikeda, T, Sasaki, A, Satoh, M, Yamaguchi, A, Noguchi, M, Nagai, I & Hiratsuka, H 2005, 'Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer', Modern Pathology, vol. 18, no. 11, pp. 1482-1489. https://doi.org/10.1038/modpathol.3800455
Shiraki, Masayuki ; Odajima, Tetsuyo ; Ikeda, Tatsuru ; Sasaki, Aya ; Satoh, Masaaki ; Yamaguchi, Akira ; Noguchi, Makoto ; Nagai, Itaru ; Hiratsuka, Hiroyoshi. / Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. In: Modern Pathology. 2005 ; Vol. 18, No. 11. pp. 1482-1489.
@article{304f2141de994533bb82e872dca3098b,
title = "Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer",
abstract = "p53, cyclin D1 and epidermal growth factor receptor (EGFR) are molecular markers that regulate the cell cycle or cell growth and play important roles in tumor development and progression. In this study, we examined the impact of immunohistochemical expression of these markers on tumor progression in 140 oral cancers. p53, cyclin D1 and EGFR were expressed in 64 cases (46{\%}), 54 cases (39{\%}) and 54 cases (39{\%}), respectively, but there was no inter-relationship between any two of these markers. In the association of these markers with clinicopathological features, EGFR expression alone was significantly associated with poor differentiation (P=0.0008) and invasive growth pattern (P=0.0003). Any of these markers, including EGFR, had no significant impact on survival. Coexpression of all these markers, however, was significantly associated with invasive growth pattern (P=0.0149) and shortened survival (P=0.0181), and was a significant and independent unfavorable prognostic factor (P=0.0002), along with tumor size (P=0.0040), nodal metastasis (P=0.0137) and growth pattern (P=0.0017) in a multivariate analysis. Simultaneous coexpression of these markers in oral cancers might prove to be a useful indicator for identification of low- or high-risk patients.",
keywords = "Coexpression, Cyclin D1, EGFR, Oral cancer, p53, Prognosis",
author = "Masayuki Shiraki and Tetsuyo Odajima and Tatsuru Ikeda and Aya Sasaki and Masaaki Satoh and Akira Yamaguchi and Makoto Noguchi and Itaru Nagai and Hiroyoshi Hiratsuka",
year = "2005",
month = "11",
doi = "10.1038/modpathol.3800455",
language = "English",
volume = "18",
pages = "1482--1489",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer

AU - Shiraki, Masayuki

AU - Odajima, Tetsuyo

AU - Ikeda, Tatsuru

AU - Sasaki, Aya

AU - Satoh, Masaaki

AU - Yamaguchi, Akira

AU - Noguchi, Makoto

AU - Nagai, Itaru

AU - Hiratsuka, Hiroyoshi

PY - 2005/11

Y1 - 2005/11

N2 - p53, cyclin D1 and epidermal growth factor receptor (EGFR) are molecular markers that regulate the cell cycle or cell growth and play important roles in tumor development and progression. In this study, we examined the impact of immunohistochemical expression of these markers on tumor progression in 140 oral cancers. p53, cyclin D1 and EGFR were expressed in 64 cases (46%), 54 cases (39%) and 54 cases (39%), respectively, but there was no inter-relationship between any two of these markers. In the association of these markers with clinicopathological features, EGFR expression alone was significantly associated with poor differentiation (P=0.0008) and invasive growth pattern (P=0.0003). Any of these markers, including EGFR, had no significant impact on survival. Coexpression of all these markers, however, was significantly associated with invasive growth pattern (P=0.0149) and shortened survival (P=0.0181), and was a significant and independent unfavorable prognostic factor (P=0.0002), along with tumor size (P=0.0040), nodal metastasis (P=0.0137) and growth pattern (P=0.0017) in a multivariate analysis. Simultaneous coexpression of these markers in oral cancers might prove to be a useful indicator for identification of low- or high-risk patients.

AB - p53, cyclin D1 and epidermal growth factor receptor (EGFR) are molecular markers that regulate the cell cycle or cell growth and play important roles in tumor development and progression. In this study, we examined the impact of immunohistochemical expression of these markers on tumor progression in 140 oral cancers. p53, cyclin D1 and EGFR were expressed in 64 cases (46%), 54 cases (39%) and 54 cases (39%), respectively, but there was no inter-relationship between any two of these markers. In the association of these markers with clinicopathological features, EGFR expression alone was significantly associated with poor differentiation (P=0.0008) and invasive growth pattern (P=0.0003). Any of these markers, including EGFR, had no significant impact on survival. Coexpression of all these markers, however, was significantly associated with invasive growth pattern (P=0.0149) and shortened survival (P=0.0181), and was a significant and independent unfavorable prognostic factor (P=0.0002), along with tumor size (P=0.0040), nodal metastasis (P=0.0137) and growth pattern (P=0.0017) in a multivariate analysis. Simultaneous coexpression of these markers in oral cancers might prove to be a useful indicator for identification of low- or high-risk patients.

KW - Coexpression

KW - Cyclin D1

KW - EGFR

KW - Oral cancer

KW - p53

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=27144546959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144546959&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800455

DO - 10.1038/modpathol.3800455

M3 - Article

C2 - 16007067

AN - SCOPUS:27144546959

VL - 18

SP - 1482

EP - 1489

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 11

ER -